Bladder Cancer

Hematuria Evaluation in Primary Care Varies Widely

Hematuria Evaluation in Primary Care Varies Widely

By

Less than half of primary care providers refer patients with any degree of hematuria for urological evaluation.

Urine Cytology Stain Detects Urothelial Carcinoma

Urine Cytology Stain Detects Urothelial Carcinoma

By

The test displayed an overall high sensitivity for detecting bladder tumors.

Complete Hematuria Evaluation Occurs in Just 1 in 6 Patients

Complete Hematuria Evaluation Occurs in Just 1 in 6 Patients

By

Men at high-risk of bladder cancer were the most likely to be referred to urologists.

'Real-World' Patient Compliance with Bladder CA Therapy Poor

'Real-World' Patient Compliance with Bladder CA Therapy Poor

By

Researchers find rates lower than those observed in most clinical trials.

Pts at High Risk of Bladder CA More Likely to Die of Other Causes

Pts at High Risk of Bladder CA More Likely to Die of Other Causes

By

Screened patients were more likely to die from other smoking-related malignancies.

Blood-Based Biomarkers May Predict Bladder Cancer Outcomes

Blood-Based Biomarkers May Predict Bladder Cancer Outcomes

By

Levels of CEA and CA 19-9 were significantly higher in patients with tumor recurrence and/or progression.

UTI Linked to Worse Bladder Cancer Outcomes

UTI Linked to Worse Bladder Cancer Outcomes

By

Greater effects were seen in women with UTI, according to researchers.

Neutrophil to Lymphocyte Ratio May Predict NMIBC Recurrence

Neutrophil to Lymphocyte Ratio May Predict NMIBC Recurrence

By

Patients who experienced recurrence had a higher ratio than those who did not.

ACE Inhibitors, ARBs May Improve NMIBC Outcomes

ACE Inhibitors, ARBs May Improve NMIBC Outcomes

By

Use of the medications was associated with a significant 39% decreased risk of tumor recurrence after surgery.

Urinary Symptoms May Raise Men's Bladder Cancer Risk

Urinary Symptoms May Raise Men's Bladder Cancer Risk

By

Men who reported having severe lower urinary tract symptoms (LUTS) had a 64% increased risk of the malignancy compared with those who reported no LUTS.

Fish Oil Might Reduce Chemo's Effectiveness

Fish Oil Might Reduce Chemo's Effectiveness

Research raises concern about the simultaneous use of chemotherapy and fish oil.

Bladder Cancer-Obesity Link Confirmed

Bladder Cancer-Obesity Link Confirmed

By

For every 5 kg/m2 increase in BMI, the risk of bladder cancer rose 4.2%.

In a New Light: NBI for Bladder Cancer

In a New Light: NBI for Bladder Cancer

Daniel Canter, M.D., discusses narrow-band imaging (NBI) for visualization of bladder cancer.

Support for Adjuvant Chemotherapy in Nonmetastatic Bladder Cancer

Support for Adjuvant Chemotherapy in Nonmetastatic Bladder Cancer

Adjuvant chemotherapy is associated with better survival among patients with advanced nonmetastatic bladder cancer.

Identifying Urothelial Cancer Subtypes Matters

Identifying Urothelial Cancer Subtypes Matters

By

It has implications for treatment decisions and prognosis.

BCG + Sunitinib Promising for High-Risk Bladder Cancer

BCG + Sunitinib Promising for High-Risk Bladder Cancer

By

In a phase 2 trial, 72% of patients with high-grade clinical nonmuscle-invasive bladder cancer had a complete response at 3 months.

Genitourinary Cancer in Siblings Raises Personal Risk

Genitourinary Cancer in Siblings Raises Personal Risk

By

Researchers found elevated familial risks for testicular, prostate, bladder, and kidney cancers.

Suicide Among Genitourinary Cancer Patients

Suicide Among Genitourinary Cancer Patients

Risk factors include male gender, distant disease, increasing age, race/ethnicity

Delayed Bladder Cancer Referrals Up Death Risk

Delayed Bladder Cancer Referrals Up Death Risk

By

In a Canadian study, long wait times before a first urologist visit was associated with a 29% higher risk of death after radical cystectomy.

Marijuana Use Found to Lower Bladder Cancer Risk in Men

Marijuana Use Found to Lower Bladder Cancer Risk in Men

By

Smoking pot decreased the likelihood of the malignancy by 45%, whereas smoking tobacco only increased the likelihood by 52%.

Bladder Cancer Adjuvant Chemotherapy Underused in the Elderly

Bladder Cancer Adjuvant Chemotherapy Underused in the Elderly

By

Patients aged 70 and older are less likely than younger patients to receive post-cystectomy treatment, despite survival benefit

Antimicrobial Prophylaxis Overused for Urological Surgeries

Antimicrobial Prophylaxis Overused for Urological Surgeries

In community practice, overall rate of compliance with AUA Best Practices is less than 60 percent

More Bladder Cancer Patients Receiving Perioperative Chemotherapy

More Bladder Cancer Patients Receiving Perioperative Chemotherapy

By

Study of patients with muscle-invasive bladder cancer documents a particularly large increase in the use of neoadjuvant chemotherapy.

Prostate Capsule, Nerve Sparing Cystectomies Offer Similar Outcomes

Prostate Capsule, Nerve Sparing Cystectomies Offer Similar Outcomes

By

In a small randomized trial, functional and oncologic results did not differ significantly between the 2 approaches

High-Risk MIBC Patients Benefit Most from Adjuvant Chemo

High-Risk MIBC Patients Benefit Most from Adjuvant Chemo

By

These include patients with positive lymph nodes and surgical margins after cystectomy.

Study Shows 'Seeding' Potential of Bladder Cancer Surgery

Study Shows 'Seeding' Potential of Bladder Cancer Surgery

By

Transurethral resection of bladder tumor can cause cancer cells to be infused into the bloodstream.

Good Survival After Laparoscopic Radical Cystectomy

Good Survival After Laparoscopic Radical Cystectomy

Recurrence-free survival was 66 percent at five years for patients with bladder cancer who had laparoscopic radical cystectomy.

FDA Clears Narrow Band Imaging for Bladder Cancer

FDA Clears Narrow Band Imaging for Bladder Cancer

By

NBI visualized non-muscle-invasive bladder cancer lesions in 17% more patients and 24% more tumors than white light.

Vitamin D May Protect Against Bladder Cancer

Vitamin D May Protect Against Bladder Cancer

By

High serum levels of vitamin D may have a protective effect against bladder cancer.

Sign Up for Free e-newsletters